200 related articles for article (PubMed ID: 11742437)
1. Health-related quality of life in individuals infected with HIV in the era of HAART.
Miners AH; Sabin CA; Mocroft A; Youle M; Fisher M; Johnson M
HIV Clin Trials; 2001; 2(6):484-92. PubMed ID: 11742437
[TBL] [Abstract][Full Text] [Related]
2. Highly active antiretroviral treatment (HAART) and health-related quality of life in naive and pretreated HIV-infected patients.
Casado A; Consiglio E; Podzamczer D; Badia X
HIV Clin Trials; 2001; 2(6):477-83. PubMed ID: 11742436
[TBL] [Abstract][Full Text] [Related]
3. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
Kempen JH; Martin BK; Wu AW; Barron B; Thorne JE; Jabs DA;
Ophthalmology; 2003 May; 110(5):987-95. PubMed ID: 12750102
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in HIV/AIDS patients on antiretroviral therapy at a tertiary care facility in Zimbabwe.
Mafirakureva N; Dzingirai B; Postma MJ; van Hulst M; Khoza S
AIDS Care; 2016 Jul; 28(7):904-12. PubMed ID: 27098289
[TBL] [Abstract][Full Text] [Related]
5. EuroQol (EQ-5D) measure of quality of life predicts mortality, emergency department utilization, and hospital discharge rates in HIV-infected adults under care.
Mathews WC; May S
Health Qual Life Outcomes; 2007 Jan; 5():5. PubMed ID: 17254361
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR
J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in a randomized trial of antiretroviral therapy for advanced HIV disease.
Joyce VR; Barnett PG; Bayoumi AM; Griffin SC; Kyriakides TC; Yu W; Sundaram V; Holodniy M; Brown ST; Cameron W; Youle M; Sculpher M; Anis AH; Owens DK
J Acquir Immune Defic Syndr; 2009 Jan; 50(1):27-36. PubMed ID: 19295332
[TBL] [Abstract][Full Text] [Related]
8. Better quality of life with neuropsychological improvement on HAART.
Parsons TD; Braaten AJ; Hall CD; Robertson KR
Health Qual Life Outcomes; 2006 Feb; 4():11. PubMed ID: 16504114
[TBL] [Abstract][Full Text] [Related]
9. The use of 2 health-related quality-of-life measures in a sample of persons infected with human immunodeficiency virus.
Delate T; Coons SJ
Clin Infect Dis; 2001 Feb; 32(3):E47-52. PubMed ID: 11170970
[TBL] [Abstract][Full Text] [Related]
10. US and UK versions of the EQ-5D preference weights: does choice of preference weights make a difference?
Huang IC; Willke RJ; Atkinson MJ; Lenderking WR; Frangakis C; Wu AW
Qual Life Res; 2007 Aug; 16(6):1065-72. PubMed ID: 17415683
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population.
Miners A; Phillips A; Kreif N; Rodger A; Speakman A; Fisher M; Anderson J; Collins S; Hart G; Sherr L; Lampe FC;
Lancet HIV; 2014 Oct; 1(1):e32-40. PubMed ID: 26423814
[TBL] [Abstract][Full Text] [Related]
12. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
13. Validity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial.
Wu AW; Jacobson KL; Frick KD; Clark R; Revicki DA; Freedberg KA; Scott-Lennox J; Feinberg J
Qual Life Res; 2002 May; 11(3):273-82. PubMed ID: 12074264
[TBL] [Abstract][Full Text] [Related]
14. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
15. Modification of medical outcome study (MOS) instrument for quality of life assessment & its validation in HIV infected individuals in India.
Kohli RM; Sane S; Kumar K; Paranjape RS; Mehendale SM
Indian J Med Res; 2005 Oct; 122(4):297-304. PubMed ID: 16394320
[TBL] [Abstract][Full Text] [Related]
16. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
17. Evaluating health-related wellbeing outcomes among outpatient adults with human immunodeficiency virus infection in the HAART era.
Saunders DS; Burgoyne RW
Int J STD AIDS; 2002 Oct; 13(10):683-90. PubMed ID: 12396538
[TBL] [Abstract][Full Text] [Related]
18. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.
Storm DS; Boland MG; Gortmaker SL; He Y; Skurnick J; Howland L; Oleske JM;
Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and impact of diarrhea on health-related quality of life in HIV-infected patients in the era of highly active antiretroviral therapy.
Siddiqui U; Bini EJ; Chandarana K; Leong J; Ramsetty S; Schiliro D; Poles M
J Clin Gastroenterol; 2007; 41(5):484-90. PubMed ID: 17450031
[TBL] [Abstract][Full Text] [Related]
20. Rate and predictors of self-chosen drug discontinuations in highly active antiretroviral therapy-treated HIV-positive individuals.
Murri R; Guaraldi G; Lupoli P; Crisafulli R; Marcotullio S; von Schloesser F; Wu AW
AIDS Patient Care STDS; 2009 Jan; 23(1):35-9. PubMed ID: 19183079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
